Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus, Carboplatin, and Paclitaxel in Cancer of Unknown Primary
NCT00936702Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in cancer of unknown primary (CUP), sponsored by Cancer and Leukemia Group B. Started Sep 2009; status: completed.
02
Drugs
everolimus
03
Conditions
cancer of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00936702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00936702.